Reasons for Treatment Changes in Patients With Moderate to Severe Psoriasis

被引:5
作者
Anderson, Kathryn L. [1 ]
Feldman, Steven R. [1 ,2 ,3 ]
机构
[1] Wake Forest Sch Med, Dept Dermatol, Ctr Dermatol Res, Winston Salem, NC 27157 USA
[2] Wake Forest Sch Med, Dept Pathol, Winston Salem, NC 27157 USA
[3] Wake Forest Sch Med, Dept Publ Hlth Sci, Winston Salem, NC 27157 USA
关键词
psoriasis; phototherapy; dermatology; TREATMENT PATTERNS; DRUG SURVIVAL; BIOLOGICS; DISCONTINUATION; POPULATION; ETANERCEPT; ADALIMUMAB; CARE; IMPAIRMENT; THERAPIES;
D O I
10.1177/1203475415572797
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Psoriasis treatment involves multiple treatment arms. Treatment choice depends on many factors and may change, due to the chronicity of psoriasis. Objective: The purpose of our study is to explore reasons for treatment changes in patients with moderate to severe psoriasis. Methods: Ten charts of patients with moderate to severe psoriasis were reviewed. The medication changes and reasons for change were extracted. A treatment change was defined as switching between medication classes, adding or removing a medication class, or switching medications within the oral or biologic medication class. Results: Seventy-seven treatment changes were identified. On average, I treatment change occurred per year of follow-up. The most common reason for treatment change was inadequate disease control. Conclusions: Inadequate disease control with current therapy is the most common reason a physician changes treatment for moderate to severe psoriasis. More efficacious treatments or ways to improve efficacy may help improve the long-term outcomes of psoriasis.
引用
收藏
页码:361 / 366
页数:6
相关论文
共 24 条
[1]   Treatment Patterns in the First Year After Initiating Tumor Necrosis Factor Blockers in Real-World Settings [J].
Bonafede, Machaon ;
Fox, Kathleen M. ;
Watson, Crystal ;
Princic, Nicole ;
Gandra, Shravanthi R. .
ADVANCES IN THERAPY, 2012, 29 (08) :664-674
[2]   Psoriasis treatment patterns with etanercept and adalimumab in a United States health plan population [J].
Chastek, Benjamin ;
Fox, Kathleen M. ;
Watson, Crystal ;
Kricorian, Gregory ;
Gandra, Shravanthi R. .
JOURNAL OF DERMATOLOGICAL TREATMENT, 2013, 24 (01) :25-33
[3]   Antihypertensive drug treatment changes in the general population: the colaus study [J].
Christe, Vanessa ;
Waeber, Gerard ;
Vollenweider, Peter ;
Marques-vidal, Pedro .
BMC PHARMACOLOGY & TOXICOLOGY, 2014, 15
[4]   Observational case series on a group of patients with severe psoriasis who failed to respond to antitumour necrosis factor α biologics and switched to ustekinumab [J].
Downs, A. M. R. .
BRITISH JOURNAL OF DERMATOLOGY, 2010, 163 (02) :433-434
[5]   Discontinuation of Methotrexate in Psoriasis [J].
Due, Eva ;
Blomberg, Maria ;
Skov, Lone ;
Zachariae, Claus .
ACTA DERMATO-VENEREOLOGICA, 2012, 92 (04) :353-354
[6]   Antihypertensive medication changes and blood pressure goal achievement in a managed care population [J].
Engel-Nitz, N. M. ;
Darkow, T. ;
Lau, H. .
JOURNAL OF HUMAN HYPERTENSION, 2010, 24 (10) :659-668
[7]   The economic impact of psoriasis increases with psoriasis severity [J].
Feldman, SR ;
Fleischer, AB ;
Reboussin, DM ;
Rapp, SR ;
Bradham, DD ;
Exum, ML ;
Clark, AR .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1997, 37 (04) :564-569
[8]   The impact of psoriasis on health care costs and patient work loss [J].
Fowler, Joseph F. ;
Duh, Mei Sheng ;
Rovba, Ludmila ;
Buteau, Sharon ;
Pinheiro, Lisa ;
Lobo, Francis ;
Sung, Jennifer ;
Doyle, Joseph J. ;
Swensen, Andrine ;
Mallett, David A. ;
Kosicki, George .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 59 (05) :772-780
[9]   Comparison of long-term drug survival and safety of biologic agents in patients with psoriasis vulgaris [J].
Gniadecki, R. ;
Bang, B. ;
Bryld, L. E. ;
Iversen, L. ;
Lasthein, S. ;
Skov, L. .
BRITISH JOURNAL OF DERMATOLOGY, 2015, 172 (01) :244-252
[10]   Comparison of drug survival rates for adalimumab, etanercept and infliximab in patients with psoriasis vulgaris [J].
Gniadecki, R. ;
Kragballe, K. ;
Dam, T. N. ;
Skov, L. .
BRITISH JOURNAL OF DERMATOLOGY, 2011, 164 (05) :1091-1096